Drug major Sun Pharmaceuticals will close its facility at Detroit as part of manufacturing consolidation.

The Workforce Development Agency for Michigan state has been notified about the decision to stop operations and close the Detroit plant, which belongs to subsidiary Caraco Pharmaceutical Laboratories, Sun Pharma said.

The generic drugmaker recently inked a $3.2 billion deal to buy Ranbaxy Laboratories.
"The company has provided the requisite advance written notice of the facility closure to the employee union and all affected employees," it added.

Impacted employees will get compensated with more than their regular entitlement under the severance package.

"They will also receive other support services, including out-placement assistance. The rest of the employees are continuing through mutually consented arrangements," it added.